Week of December 12, 2023 | Vol. 12, Issue 48

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Absci, AstraZeneca Enter AI-Driven Oncology Alliance

Contract Pharma - Dec 4, 2023

Fierce Healthcare's 2023 Women of Influence

Fierce Healthcare - Dec 4, 2023

Kindeva Drug Delivery and Orbia Fluorinated Solutions (Koura) Announce Collaboration for Low GWP Propellant Conversion

Business Wire - Dec 5, 2023

Pfizer, Valneva overcome CRO issues to finish phase 3 recruitment for Lyme disease vaccine

Fierce Biotech - Dec 5, 2023

Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

PR Newswire - Dec 6, 2023

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

LTS - Dec 6, 2023

Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study

PR Newswire - Dec 6, 2023

Novartis makes investment in AI firm Yseop for clinical trial writing

Fierce Biotech - Dec 7, 2023

FACT SHEET: Biden-⁠Harris Administration Announces New Actions to Lower Health Care and Prescription Drug Costs by Promoting Competition

The White House - Dec 7, 2023

bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events

bluebird bio - Dec 8, 2023

TANNER NEWS

A Journey of Compassion and Dedication

Tanner Pharma proudly served as the title sponsor for The Max Foundation’s “Max Global Experience: Cambodia.” Check out this quick video recap for scenes and takeaways from the trip.